XNAS: INCY
Incyte Live Stock Price Today, Share Analysis and Chart
about
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheuma...
Read More
107.46
-1.00
(-0.92%)
760.4K
XNAS Volume
XNAS 25 Jun, 2026 1:36 PM (EDT)
Medium Financial Strength
Affordable Valuation
Technically Moderately Bullish
Turnaround Potential
These stocks have average financials with good valuations and momentum, indicating turnaround potential
View Similar
Embed DVM
Incyte Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..